Zobrazeno 1 - 10
of 211
pro vyhledávání: '"Hiroyuki Watanabe"'
Autor:
Tatsuya Nakama, Shigeo Ichihashi, Kenji Ogata, Shunsuke Kojima, Makio Muraishi, Kotaro Obunai, Hiroyuki Watanabe
Publikováno v:
CardioVascular and Interventional Radiology. 45:622-632
A dedicated treatment strategy is not yet established for patients with no-option chronic limb-threatening ischemia. This study aimed to evaluate the clinical outcomes of percutaneous deep venous arterialization in Japanese patients with no-option ch
Publikováno v:
Internal Medicine
Objective Percutaneous patent foramen ovale (PFO) closure is a procedure widely used to prevent recurrence of cryptogenic stroke. Since December 2019, the Amplatzer PFO occluder device has been available in Japan through medical insurance. However, d
Publikováno v:
Journal of Hepato-Biliary-Pancreatic Sciences. 29:531-539
Invasive gallbladder carcinoma generally presents as nodular-sclerosing growth. Recently, "polypoid invasive carcinoma (PICA)" showing grossly visible polypoid neoplasm and histologically invasive carcinoma with no adenomatous components was proposed
Autor:
Huanlin Wang, Noboru Harada, Kojiro Hata, Shinji Itoh, Katsuya Toshida, Tomonari Shimagaki, Tomoharu Yoshizumi, Hiroyuki Watanabe, Yoshihiro Nagao, Takeshi Kurihara, Yoko Makihara, Masaki Mori, Takeo Toshima
Publikováno v:
Surgery Today. 52:441-448
Lenvatinib (LEN) is a molecular-target drug, used for unresectable hepatocellular carcinoma (HCC). It is associated with adverse events (AEs), including hypertension, proteinuria, fatigue, and anorexia, which may force dose reduction or discontinuati
Autor:
Satohiro Masuda, Tomoharu Yoshizumi, Masatake Tanaka, Ichiro Ieiri, Yoko Makihara, Motoyuki Kohjima, Kimitaka Suetsugu, Kojiro Hata, Nobuaki Egashira, Hiroyuki Watanabe, Shinji Itoh
Publikováno v:
Cancer Chemotherapy and Pharmacology. 86:803-813
This study aimed to examine the association between the trough plasma concentration of lenvatinib with the objective response rate (ORR) and adverse events in patients with hepatocellular carcinoma (HCC). Twenty-one patients with HCC who received len
Autor:
Hiroyuki Watanabe, Akihiro Tanaka, Taku Sanada, Kazuo Notsumata, Teruyuki Ueda, Daisyu Toya, Yoshimoto Nomura, Yoshikatsu Nomura
Publikováno v:
Internal Medicine
Objective We started an information technology (IT) system that encodes the medical treatment status of hepatitis B virrus (HBV) with a 9-digit number, automatically checks for inappropriate situations occurring due to immunosuppression and chemother
Autor:
Kenzo Hirao, Nami Omori, Nahoko Kato, Mizuho Hoshina, Hiroyuki Watanabe, Kotaro Obunai, Yu Makihara, Hiroshi Okumura, Patricia A. Pellikka, Minoru Tabata, Kentaro Shibayama
Publikováno v:
Journal of Cardiology. 74:532-538
Background Mitral stenosis (MS) is often concomitant with aortic stenosis (AS). However, little is known about the functional status following transcatheter aortic valve replacement (TAVR) alone in patients with severe AS and MS and the impact of TAV
Autor:
Kenta Watanabe, Shigeto Koizumi, Kenji Shirane, Hidehiko Tsuda, Hiroyuki Watanabe, Tsuyotoshi Tsuji, Kengo Onochi, Kiyonori Yamai, Chika Kusano, Takahiro Dohmen, Yohei Horikawa, Takuma Ajimine, Masahiro Saito, Tomoyuki Koike, Atsushi Masamune, Yosuke Shimodaira, Tamotsu Matsuhashi, Katsunori Iijima
Publikováno v:
Esophagus : official journal of the Japan Esophageal Society. 19(3)
While an association between esophago-gastric junctional adenocarcinomas (EGJACs) and obesity, especially visceral obesity, has been suggested in Western countries, the association remains unclear in Asia, including Japan. In this population-based ca
Autor:
Yoichi Nakanishi, Kojiro Hata, Ryosuke Matsukane, Isamu Okamoto, Ichiro Ieiri, Hiroyuki Watanabe, Kimitaka Suetsugu, Toshikazu Tsuji, Nobuaki Egashira
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
The liver is an essential organ for regulating innate and acquired immunity. We hypothesized that the pre-treatment hepatic function affects the clinical outcome of immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC). We analyze
Autor:
Shigeto Koizumi, Kae Sugawara, Nobuya Mimori, Kengo Onochi, Yohei Horikawa, Hiroyuki Watanabe, Shusei Fujimori, Hajime Ishii, Tsuyotoshi Tsuji, Katsunori Iijima
Publikováno v:
Journal of Gastroenterology. 54:963-971
The incidence of peptic ulcers unrelated to H. pylori infection and non-steroidal anti-inflammatory drugs (NSAIDs), termed idiopathic peptic ulcers (IPUs), has increased worldwide. We recently reported that IPUs were refractory to proton pump inhibit